Device
Extracorporeal Shock Wave Therapy (Device)
Extracorporeal Shock Wave Therapy (Device) is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
unknown1
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
unknown133%
completed133%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
Effect of Extracorporeal Shock Wave Combined With Autologous Platelet-rich Plasma Injection on Rotator Cuff Calcific Tendinitis
NCT06372600
unknownnot_applicable
Comparison of the Efficiency of ESWT and Ozone Injection in Patients With Chronic Plantar Fasciitis
NCT06041230
completednot_applicable
Change and Clinical Significance of Plantar Fascia Thickness After ESWT
NCT00155324
Clinical Trials (3)
Showing 3 of 3 trials
NCT06372600Not Applicable
Effect of Extracorporeal Shock Wave Combined With Autologous Platelet-rich Plasma Injection on Rotator Cuff Calcific Tendinitis
NCT06041230Not Applicable
Comparison of the Efficiency of ESWT and Ozone Injection in Patients With Chronic Plantar Fasciitis
NCT00155324Not Applicable
Change and Clinical Significance of Plantar Fascia Thickness After ESWT
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3